Our work revealed the roles of ARSD in anti-tumor immunity of glioma, and found that ARSD expression exhibited a positive correlation with the scores of Step4 and Step1 in the Cancer-Immunity Cycle, while displaying a negative correlation with the scores of Step7, Step5, Step3, and Step2 (Figures 5F, G). Here, ARSD is linked to cancer.